Evidence map›Paper›PMID 29489050›Full record

ArticleBJU international2018

Urinary, bowel and sexual health in older men from Northern Ireland.

David W Donnelly, Conan Donnelly, Therese Kearney, David Weller, Linda Sharp, Amy Downing, Sarah Wilding, Penny Wright, Paul Kind, James W F Catto and 19 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJU international, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

David W DonnellyNorthern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, UK.ORCID 0000-0003-0076-7685
Conan DonnellyNational Cancer Registry Ireland, Cork, Ireland.
Therese KearneyNorthern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, UK.
David WellerCentre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
Linda SharpInstitute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.
Amy DowningLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Sarah WildingLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Penny WrightLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.ORCID 0000-0001-6129-4143
Paul KindInstitute of Health Sciences, University of Leeds, Leeds, UK.
James W F CattoAcademic Urology Unit, University of Sheffield, Sheffield, UK.
William R CrossDepartment of Urology, St James's University Hospital, Leeds, UK.
Malcolm D MasonDivision of Cancer and Genetics, School of Medicine, Velindre Hospital, Cardiff University, Cardiff, UK.
Eilis McCaughanInstitute of Nursing and Health Research, Ulster University, Coleraine, UK.
Richard WaglandFaculty of Health Sciences, University of Southampton, Southampton, UK.
Eila WatsonFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Rebecca MottramLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Majorie AllenLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Hugh ButcherYorkshire Cancer Patient Forum, c/o Strategic Clinical Network and Senate, Yorkshire and The Humber, Harrogate, UK.
Luke HounsomeNational Cancer Registration and Analysis Service, Public Health England, Bristol, UK.
Peter SelbyLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Dyfed HuwsWelsh Cancer Intelligence and Surveillance Unit, Cardiff, UK.
David H BrewsterInformation Services Division, NHS National Services Scotland, Edinburgh, UK.
Emma McNairInformation Services Division, NHS National Services Scotland, Edinburgh, UK.
Carol RivasDepartment of Social Science, UCL Institute of Education, University College London, London, UK.
Johana NayoanFaculty of Health Sciences, University of Southampton, Southampton, UK.
Mike HortonPsychometric Laboratory for Health Sciences, Academic Department of Rehabilitation Medicine, University of Leeds, Leeds, UK.
Lauren MathesonFaculty of Health and Life Sciences, Oxford Brookes University, Oxford, UK.
Adam W GlaserLeeds Institute of Cancer and Pathology/Leeds Institute of Data Analytics, University of Leeds, Leeds, UK.
Anna GavinNorthern Ireland Cancer Registry, Centre for Public Health, Queen's University Belfast, Belfast, UK.

Funding

Department of Health HS&DR/14/156/15Department of Health RP-PG-0707-10101
6 · The paper itself

Abstract

objectivesTo provide data on the prevalence of urinary, bowel and sexual dysfunction in Northern Ireland (NI), to act as a baseline for studies of prostate cancer outcomes and to aid service provision within the general population. SUBJECTS AND

methodsA cross-sectional postal survey of 10 000 men aged ≥40 years in NI was conducted and age-matched to the distribution of men living with prostate cancer. The EuroQoL five Dimensions five Levels (EQ-5D-5L) and 26-item Expanded Prostate Cancer Composite (EPIC-26) instruments were used to enable comparisons with prostate cancer outcome studies. Whilst representative of the prostate cancer survivor population, the age-distribution of the sample differs from the general population, thus data were generalised to the NI population by excluding those aged 40-59 years and applying survey weights. Results are presented as proportions reporting problems along with mean composite scores, with differences by respondent characteristics assessed using chi-squared tests, analysis of variance, and multivariable log-linear regression.

resultsAmongst men aged ≥60 years, 32.8% reported sexual dysfunction, 9.3% urinary dysfunction, and 6.5% bowel dysfunction. In all, 38.1% reported at least one problem and 2.1% all three. Worse outcome was associated with increasing number of long-term conditions, low physical activity, and higher body mass index (BMI). Urinary incontinence, urinary irritation/obstruction, and sexual dysfunction increased with age; whilst urinary incontinence, bowel, and sexual dysfunction were more common among the unemployed.

conclusionThese data provide an insight into sensitive issues seldom reported by elderly men, which result in poor general health, but could be addressed given adequate service provision. The relationship between these problems, raised BMI and low physical activity offers the prospect of additional health gain by addressing public health issues such as obesity. The results provide essential contemporary population data against which outcomes for those living with prostate cancer can be compared. They will facilitate greater understanding of the true impact of specific treatments such as surgical interventions, pelvic radiation or androgen-deprivation therapy.

Indexed as

AdultAgedAged, 80 and overCross-Sectional StudiesHumansIntestinal DiseasesMaleMen's HealthMiddle AgedNorthern IrelandPrevalenceSexual Dysfunction, PhysiologicalUrination Disordersbowel dysfunctionhealth-related quality of lifeLife After Prostate Cancer Diagnosisprostate cancersexual dysfunctionurinary dysfunction

Identifiers

PMID29489050
PMCPMC6220963

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.